Raucci Maria Grazia, D'Amora Ugo, Ronca Alfredo, Ambrosio Luigi
Institute of Polymers, Composites and Biomaterials, National Research Council (IPCB-CNR), Viale J.F. Kennedy 54, Mostra d'Oltremare Pad.20, Naples, 80125, Italy.
Adv Healthc Mater. 2020 Jul;9(13):e2000349. doi: 10.1002/adhm.202000349. Epub 2020 Jun 2.
Injectable materials represent very attractive ready-to-use biomaterials for application in minimally invasive surgical procedures. It is shown that this approach to treat, for example, vertebral fracture, craniofacial defects, or tumor resection has significant clinical potential in the biomedical field. In the last four decades, calcium phosphate cements have been widely used as injectable materials for orthopedic surgery due to their excellent properties in terms of biocompatibility and osteoconductivity. However, few clinical studies have demonstrated certain weaknesses of these cements, which include high viscosity, long degradation time, and difficulties being manipulated. To overcome these limitations, the use of sol-gel technology has been investigated, which has shown good results for synthesis of injectable calcium phosphate-based materials. In the last few decades, injectable hydrogels have gained increasing attention owing to their structural similarities with the extracellular matrix, easy process conditions, and potential applications in minimally invasive surgery. However, the need to protect cells during injection leads to the development of double network injectable hydrogels that are capable of being cross-linked in situ. This review will provide the current state of the art and recent advances in the field of injectable biomaterials for minimally invasive surgery.
可注射材料是用于微创手术的极具吸引力的即用型生物材料。研究表明,这种治疗方法,例如用于治疗椎体骨折、颅面缺损或肿瘤切除,在生物医学领域具有巨大的临床潜力。在过去的四十年里,磷酸钙骨水泥因其在生物相容性和骨传导性方面的优异性能,被广泛用作骨科手术的可注射材料。然而,很少有临床研究证明这些骨水泥存在某些弱点,包括高粘度、降解时间长以及操作困难。为了克服这些局限性,人们对溶胶 - 凝胶技术的应用进行了研究,该技术在合成可注射磷酸钙基材料方面显示出良好的效果。在过去的几十年里,可注射水凝胶因其与细胞外基质的结构相似性、简便的加工条件以及在微创手术中的潜在应用而受到越来越多的关注。然而,在注射过程中保护细胞的需求促使了能够原位交联的双网络可注射水凝胶的发展。本综述将介绍用于微创手术的可注射生物材料领域的当前技术水平和最新进展。